Telomerase: central regulator of all of the hallmarks of cancer
- PMID: 23932019
- DOI: 10.1016/j.tibs.2013.07.001
Telomerase: central regulator of all of the hallmarks of cancer
Abstract
The hallmarks of cancer described by Hanahan and Weinberg are properties that cancer cells must possess for successful transformation. It is believed that each of these hallmarks is independently driven. Although elongation of telomeres is thought to be the prime function of reactivated telomerase reverse transcriptase, this activity does not account for all its effects, such as increasing cell proliferation, resistance to apoptosis, and invasion. Recent studies suggest that the telomerase subunit telomerase reverse transcriptase (TERT) has novel molecular functions including transcriptional regulation and metabolic reprogramming. We summarize these functions and discuss how they could directly regulate the various hallmarks of cancer. Finally, we suggest that therapeutics targeting noncanonical telomerase functions may work better than those that target its role in telomere extension.
Keywords: apoptosis; cancer; hTERT; signaling; telomere.
2013 Elsevier Ltd. All rights reserved
Similar articles
-
Telomerase and hallmarks of cancer: An intricate interplay governing cancer cell evolution.Cancer Lett. 2023 Dec 1;578:216459. doi: 10.1016/j.canlet.2023.216459. Epub 2023 Oct 19. Cancer Lett. 2023. PMID: 37863351 Review.
-
Feedback regulation of telomerase reverse transcriptase: new insight into the evolving field of telomerase in cancer.Cell Signal. 2013 Dec;25(12):2462-8. doi: 10.1016/j.cellsig.2013.08.009. Epub 2013 Aug 29. Cell Signal. 2013. PMID: 23993966 Review.
-
Noncanonical functions of telomerase: implications in telomerase-targeted cancer therapies.Cancer Res. 2014 Mar 15;74(6):1639-44. doi: 10.1158/0008-5472.CAN-13-3568. Epub 2014 Mar 5. Cancer Res. 2014. PMID: 24599132 Review.
-
Telomerase reverse transcriptase in the regulation of gene expression.BMB Rep. 2014 Jan;47(1):8-14. doi: 10.5483/bmbrep.2014.47.1.284. BMB Rep. 2014. PMID: 24388106 Free PMC article. Review.
-
Telomerase: not just for the elongation of telomeres.Bioessays. 2006 Feb;28(2):109-12. doi: 10.1002/bies.20365. Bioessays. 2006. PMID: 16435298
Cited by
-
Therapeutic targeting of FOS in mutant TERT cancers through removing TERT suppression of apoptosis via regulating survivin and TRAIL-R2.Proc Natl Acad Sci U S A. 2021 Mar 16;118(11):e2022779118. doi: 10.1073/pnas.2022779118. Proc Natl Acad Sci U S A. 2021. PMID: 33836600 Free PMC article.
-
Wnts and the hallmarks of cancer.Cancer Metastasis Rev. 2020 Sep;39(3):625-645. doi: 10.1007/s10555-020-09887-6. Cancer Metastasis Rev. 2020. PMID: 32385713 Review.
-
Multi‑layered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/β‑catenin signaling activation (Review).Int J Mol Med. 2018 Aug;42(2):713-725. doi: 10.3892/ijmm.2018.3689. Epub 2018 May 17. Int J Mol Med. 2018. PMID: 29786110 Free PMC article. Review.
-
Phase 1 study of safety, tolerability and immunogenicity of the human telomerase (hTERT)-encoded DNA plasmids INO-1400 and INO-1401 with or without IL-12 DNA plasmid INO-9012 in adult patients with solid tumors.J Immunother Cancer. 2021 Jul;9(7):e003019. doi: 10.1136/jitc-2021-003019. J Immunother Cancer. 2021. PMID: 34230114 Free PMC article. Clinical Trial.
-
Precision medicine for hepatocellular carcinoma: driver mutations and targeted therapy.Oncotarget. 2017 Jun 6;8(33):55715-55730. doi: 10.18632/oncotarget.18382. eCollection 2017 Aug 15. Oncotarget. 2017. PMID: 28903454 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources